STEVE ASELAGE - 01 Nov 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Issuer symbol
TVTX
Transactions as of
01 Nov 2021
Net transactions value
-$252,400
Form type
4
Filing time
03 Nov 2021, 16:05:54 UTC
Previous filing
08 Oct 2021
Next filing
09 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Gift $0 -25,000 -13% $0.000000 164,794 04 Feb 2021 Direct
transaction TVTX Common Stock Gift $0 +25,000 $0.000000 25,000 04 Feb 2021 See footnote F1
transaction TVTX Common Stock Gift $0 -3,000 -1.8% $0.000000 161,794 16 Jul 2021 Direct
transaction TVTX Common Stock Gift $0 +3,000 +12% $0.000000 28,000 16 Jul 2021 See footnote F1
transaction TVTX Common Stock Sale $147,400 -5,000 -18% $29.48 23,000 01 Nov 2021 See footnote F1, F2, F3
transaction TVTX Common Stock Sale $105,000 -3,500 -15% $30.00 19,500 02 Nov 2021 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held in the name of the Aselage Family Trust.
F2 The sales reported in this Form 4 were effected pursuant to an automatic trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.065 to $29.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.